Results 51 to 60 of about 798,993 (253)

A case of cerebral venous thrombosis following the use of contraceptive medication

open access: yesSouth African Journal of Radiology, 2000
Cerebral venous thrombosis is an uncommon and serious complication of contraceptive medication, which often masquerades as a simple headache. The clinical picture is often confusing and imaging is critical to the diagnosis of this disorder.
G. Bunea, I. B. Copley, O. Ajani
doaj   +1 more source

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

open access: yesAdvanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin   +3 more
wiley   +1 more source

Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report

open access: yesFrontiers in Neurology, 2021
This study reported two cases of intracranial thrombotic events of aplastic anemia (AA) under therapy with cyclosporine-A (CsA) and reviewed both drug-induced cerebral venous thrombosis (CVT) and CsA-related thrombotic events systematically.
Si-ying Song   +13 more
doaj   +1 more source

Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic

open access: yesAdvanced Robotics Research, EarlyView.
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang   +5 more
wiley   +1 more source

Cerebral venous sinus thrombosis associated with COVID-19 [PDF]

open access: yes, 2020
Coronavirus disease of 2019 (COVID-19) is well known to increase the risk of developing venous thromboembolism and so may present first to neurologists owing to development of cerebral venous sinus thrombosis. We present a patient presenting acutely with
Thompson, Ameeka   +8 more
core   +2 more sources

Inhibition of MEKK3 Prevents Cerebral Cavernous Malformation Progression Via Restoring Endothelial Integrity and Restricting Microglial Activation

open access: yesAdvanced Science, EarlyView.
In this study, we demonstrate that aberrant MEKK3 signaling in endothelial cells and microglia drives the progression of cerebral cavernous malformations (CCMs). Furthermore, we identify DPDH as a potent small‐molecule MEKK3 inhibitor with substantial therapeutic potential for CCM treatment.
Weiwei Zheng   +17 more
wiley   +1 more source

A Novel Bioactive Component, Efoba, From Aged Garlic Targets CTSC to Suppress NET‐Driven Neuroinflammation and Ameliorate Secondary Brain Injury After Intracerebral Hemorrhage

open access: yesAdvanced Science, EarlyView.
Efoba, a novel bioactive component derived from aged garlic, confers neuroprotection against intracerebral hemorrhage. It acts on microglia to suppress CTSC release, inhibits NET‐mediated neural injury, and blocks pathological microglia‐neutrophil crosstalk. This study provides a highly promising lead compound for hemorrhagic‐stroke therapy.
Junjun Meng   +7 more
wiley   +1 more source

A case of bilateral lower motor neuron facial palsy in cerebral venous sinus thrombosis

open access: yesAPIK Journal of Internal Medicine, 2021
Cerebral venous thrombosis commonly presents with headache, seizure, and motor weakness. Among cranial nerves, the abducens nerve is common to get involved.
Vaishal Shah, Vijay Sardana
doaj   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra   +3 more
wiley   +1 more source

Factors associated with venous collaterals in patients with cerebral venous thrombosis.

open access: yesPLoS ONE
ObjectivesTo identify the factors associated with venous collaterals in Thai patients with cerebral venous thrombosis.Materials and methodsThis retrospective 20-year cohort study enrolled patients diagnosed with cerebral venous thrombosis between January
Phirat Petchprom   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy